Investor Relations
Tvardi Therapeutics, Inc. is a clinical-stage, biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat inflammatory and proliferative diseases with significant unmet need.
Minimum 15 minutes delayed. Source: LSEG